cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine has been researched along with Disease Models, Animal in 3 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borysko, K; Breitenbach, J; Drach, JC; Hilfinger, J; Kashemirov, BA; Kijek, P; Kim, JS; McKenna, CE; Mitchell, S; Peterson, LW | 1 |
Bernstein, DI; Bourne, N; Bravo, FJ; Schleiss, MR | 1 |
Bernstein, DI; Bravo, FJ; Cardin, RD | 1 |
3 other study(ies) available for cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and Disease Models, Animal
Article | Year |
---|---|
Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.
Topics: Administration, Oral; Alanine; Animals; Antiviral Agents; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Molecular Structure; Organophosphonates; Peptides; Prodrugs; Rats; Serine; Valine | 2011 |
An animal model of neonatal cytomegalovirus infection.
Topics: Animals; Animals, Newborn; Antiviral Agents; Body Weight; Brain; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Guinea Pigs; Liver; Lung; Organophosphorus Compounds; Spleen; Virus Replication | 2003 |
Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.
Topics: Animals; Animals, Newborn; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Female; Guinea Pigs; Immunity, Maternally-Acquired; Infectious Disease Transmission, Vertical; Organophosphorus Compounds; Pregnancy; Pregnancy Outcome; Virus Replication | 2006 |